Successful Management of Folliculitis Decalvans

January 2024 in “ Cureus ”

Yash Kashikar, Vikrant Saoji, Bhushan Madke, Meenakshi Chandak, Soham Meghe

folliculitis decalvans scarring alopecia Staphylococcus aureus doxycycline ozenoxacin

Folliculitis decalvans (FD) is a rare inflammatory scalp disease causing scarring alopecia, primarily affecting young and middle-aged men. This report details a 20-year-old male with FD, presenting with painful pustules on the scalp. The condition, potentially linked to Staphylococcus aureus and influenced by genetic and immunological factors, was treated successfully with a month-long regimen of doxycycline and topical ozenoxacin, resulting in remission of the lesions.

View this study on assets.cureus.com →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Updates in Therapeutics for Folliculitis Decalvans: A Systematic Review with Evidence-Based Analysis

40 citations, August 2018 in “Journal of the American Academy of Dermatology”

Clindamycin and rifampicin are the most effective treatments for folliculitis decalvans, but more research is needed.

research Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-Standing Cases

43 citations, January 2015 in “Journal of Cutaneous Medicine and Surgery”

Most patients improved with oral antibiotics, but some needed long-term treatment or had minimal response.

research Effective Treatment of Folliculitis Decalvans Using Selected Antimicrobial Agents

33 citations, January 2010 in “International journal of trichology”

Antimicrobial therapy can help manage Folliculitis Decalvans.

research Folliculitis Decalvans: A Rare Inflammatory Scalp Disorder

112 citations, July 2008 in “Dermatologic Therapy”

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Related Community Posts Join

6 / 49 results

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 3 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community The Worst Hair Loss Condition You (MAY) have: LPP

in Research/Science 43 upvotes 2 months ago

Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

community I tried salt water to stop the DHT itch

in Treatment 60 upvotes 1 year ago

Treating the itch associated with male pattern baldness, which is believed to be caused by DHT. Potential treatments discussed include salt water, finasteride, ketoconazole, and RU58841.

community Seb derm regrowth progress? I think? Or am I just seeing what I want to see?

in Is this regrowth? 48 upvotes 7 months ago

A person with hair loss due to seborrheic dermatitis saw improvement after treating the condition and using 5mg oral minoxidil, topical minoxidil, collagen, biotin, and vitamins. They are asking if the progress is real, and others have noted the oral minoxidil as a significant treatment.

community Eliminating scalp itch leads to regrowth (and my RU58841 progress)

in Research/Science 61 upvotes 1 year ago

User experienced hair regrowth after eliminating scalp itch with RU58841. Others discussed itch and hair loss connection, and effectiveness of combining RU58841 with 5AR inhibitors.

community How I paused my hair loss by curing seborrheic dermatitis

in Treatment 107 upvotes 1 year ago

User Wonderful_Tonight910 suffered from hair loss and seborrheic dermatitis for years. After using irritant-free shampoo, their scalp improved, hair loss stopped, and new hair growth appeared.

Similar Research

5 / 1000+ results

research Folliculitis Decalvans: A Review of Current Treatment Modalities

May 2024 in “Journal of Education, Health and Sport”

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Folliculitis Decalvans: Effectiveness of Therapies and Prognostic Factors in a Multicenter Series of 60 Patients with Long-Term Follow-Up

research Folliculitis Decalvans: Effectiveness of Therapies and Prognostic Factors in a Multicenter Series of 60 Patients with Long-Term Follow-Up

41 citations, June 2018 in “Journal of The American Academy of Dermatology”

Some treatments for folliculitis decalvans work well, with tetracyclines and a mix of rifampicin and clindamycin being most effective.

research Female Hair Loss: Assessment, Categorization, and Management

July 2019 in “InnovAiT”

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

A Case of Folliculitis Decalvans With Concomitant Acne Keloidalis Nuchae, Androgenic Alopecia, and Profound Postinflammatory Hyperpigmentation

research A Case of Folliculitis Decalvans With Concomitant Acne Keloidalis Nuchae, Androgenic Alopecia, and Profound Postinflammatory Hyperpigmentation

April 2019 in “Journal of the Dermatology Nurses’ Association”

A 37-year-old man with hair loss and skin issues was successfully treated with oral antibiotics, highlighting the need for early treatment. Long-term care includes low-dose antibiotics and avoiding caps and wigs.

$Refractory Folliculitis Decalvans Treatment Success with a Novel Surgical Excision Approach Using Guarded High-Tension Sutures$

research Refractory Folliculitis Decalvans Treatment Success with a Novel Surgical Excision Approach Using Guarded High-Tension Sutures

September 2023 in “Clinical, cosmetic and investigational dermatology”

A new surgical method using special sutures significantly reduced wound size and prevented disease return in patients with a scarring scalp condition.